Concurrent stroke and ST-elevation myocardial infarction: Is it a contraindication for intravenous tenecteplase?

Wan Asyraf WZ 1 , Elengoe S 2 , Che Hassan HH 3 , Abu Bakar A 4 , Remli R 2

Affiliations 

  • 1 Pusat Perubatan Universiti Kebangsaan Malaysia, Medical Department, Neurology unit, Kuala Lumpur, Malaysia. wan.asyraf.wan.zaidi@ppukm.ukm.edu.my
  • 2 Pusat Perubatan Universiti Kebangsaan Malaysia, Medical Department, Neurology unit, Kuala Lumpur, Malaysia
  • 3 Pusat Perubatan Universiti Kebangsaan Malaysia, Medical Department, Cardiology unit, Kuala Lumpur, Malaysia
  • 4 Pusat Perubatan Universiti Kebangsaan Malaysia, Emergency department, Kuala Lumpur, Malaysia
Med J Malaysia, 2020 03;75(2):169-170.
PMID: 32281601

Abstract

Acute ischemic stroke (AIS) and acute ST-elevation myocardial infarction (STEMI) are leading causes of mortality worldwide. Concurrent AIS presentation with STEMI is rare and potentially fatal. Most importantly to date many centres in Malaysia are still not aware on how to treat this condition. We report a case of AIS, which was treated with intravenous tenecteplase (TNK) according to ischemic stroke dosage and lead to improvement of neurological deficit.

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

MeSH terms
Similar publications